XNCR Q2 2020 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$861M

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$13M-32.8% YoY

Gross Profit

-$30M-232.0% margin

Operating Income

-$38M-287.3% margin

Net Income

-$35M-267.5% margin

EPS (Diluted)

$-0.61

QoQ Revenue Growth

-59.6%

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$29M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$645M

Total Liabilities

$74M

Stockholders' Equity

$571M

Cash & Equivalents

$110M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$19M	-32.8%
Gross Profit	-$30M	-$14M	-119.8%
Operating Income	-$38M	-$20M	-92.1%
Net Income	-$35M	-$16M	-118.4%

Revenue Segments

License

$8M57%

Royalty

$4M29%

Collaboration

$2M11%

Milestone

$300,0002%